Spero Therapeutics (SPRO) Shares Issued (2018 - 2023)

Spero Therapeutics (SPRO) has 6 years of Shares Issued data on file, last reported at $1000.0 in Q4 2023.

• For the quarter ending Q4 2023, Shares Issued rose 100.01% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2024 stood at $221000.0 (changed 0.0% YoY), and the FY2023 full-year result was $221000.0, down 47.38% from the prior year.
• Shares Issued for Q4 2023 stood at $1000.0, down from $220000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $40.0 million in Q2 2021 and bottomed at -$38.9 million in Q3 2021.
• The 5-year median for Shares Issued is $250500.0 (2020), against an average of $3.9 million.
• Peak annual rise in Shares Issued reached 14769.89% in 2021, while the deepest fall reached 19440.8% in 2021.
• A 5-year view of Shares Issued shows it stood at $5.5 million in 2019, then soared by 121.0% to $12.2 million in 2020, then tumbled by 98.09% to $232000.0 in 2021, then tumbled by 4373.28% to -$9.9 million in 2022, then soared by 100.01% to $1000.0 in 2023.
• The last three Shares Issued figures came in at $1000.0 (Q4 2023), $220000.0 (Q3 2023), and -$9.9 million (Q4 2022), per Business Quant data.

Peer Comparison